InTrack Investment Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.2M Sell
3,505
-109
-3% -$111K 2.08% 13
2026
Q1
$3.32M Sell
3,614
-58
-2% -$58.8K 1.89% 15
2025
Q4
$3.95M Buy
3,672
+292
+9% +$279K 2.21% 13
2025
Q3
$2.58M Buy
3,380
+660
+24% +$491K 1.54% 20
2025
Q2
$2.12M Sell
2,720
-230
-8% -$179K 1.42% 20
2025
Q1
$2.44M Sell
2,950
-1,566
-35% -$1.3M 2.21% 11
2024
Q4
$3.36M Buy
4,516
+1,011
+29% +$837K 2.35% 7
2024
Q3
$3.11M Sell
3,505
-643
-16% -$578K 2.2% 6
2024
Q2
$3.76M Buy
4,148
+495
+14% +$396K 2.67% 5
2024
Q1
$2.84M Sell
3,653
-425
-10% -$302K 2.11% 6
2023
Q4
$2.38M Buy
4,078
+558
+16% +$326K 1.78% 8
2023
Q3
$1.89M Sell
3,520
-1,950
-36% -$1M 1.66% 8
2023
Q2
$2.57M Sell
5,470
-730
-12% -$306K 2.09% 6
2023
Q1
$2.2M Buy
+6,200
New +$2.09M 2.01% 6

Other funds holding LLY

InTrack Investment Management's LLY Position: Q2 2026 in Review

InTrack Investment Management reduced its Eli Lilly (LLY) stake by 3% in Q2 2026, selling an estimated $111K and leaving 3,505 shares worth $4.2M. The position accounts for 2.08% of the portfolio, ranked #13.

InTrack Investment Management first reported a position in LLY in Q1 2023 and has held it in 14 quarters since. 961 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • InTrack Investment Management held 3,505 shares of Eli Lilly worth $4.2M as of Q2 2026.
  • InTrack Investment Management sold 109 Eli Lilly shares in Q2 2026, an estimated $111K.
  • Eli Lilly made up 2.08% of InTrack Investment Management's portfolio in Q2 2026, its #13 holding.
  • InTrack Investment Management first reported a position in Eli Lilly in Q1 2023 and has held it in 14 quarters since.
  • 961 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on InTrack Investment Management's 13F filing for Q2 2026, filed 17 Jul 2026.